Logo image
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies
Journal article

Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies

William Y. Raynor, Mahdi Zirakchian Zadeh, Esha Kothekar, Dani P. Yellanki and Abass Alavi
PET clinics, v 14(3), pp 331-340
01 Jul 2019
PMID: 31084773

Abstract

Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging Science & Technology
The role of F-18-fluorodeoxyglucose PET/computed tomography in hematological malignancies continues to expand in disease diagnosis, staging, and management. A key advantage of PET over other imaging modalities is its ability to quantify tracer uptake, which can be used to determine degree of disease activity. Although tracer uptake with PET is conventionally measured in focal lesions, novel quantitative techniques are being investigated that set objective protocols and produce robust parameters that represent total disease activity portrayed by PET. This article discusses recent advances in PET quantification that can improve reliability and accuracy of characterizing hematological malignancies.

Metrics

7 Record Views
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
Logo image